Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2141473 | 0.83 | ALDH1A1 (0.50) | ALDH1A1CYP3A4 | |
| SCHEMBL10597988 | 0.81 | CYP3A4 (0.38) | ALDH1A1CYP3A4 | |
| SCHEMBL8463495 | 0.81 | CYP3A4 (0.38) | ALDH1A1CYP3A4 | |
| SCHEMBL11248848 | 0.80 | ALDH1A1 (0.48) | ALDH1A1CYP3A4 | |
| SCHEMBL5851894 | 0.80 | CYP3A4 (0.41) | ALDH1A1CYP3A4 | |
| SCHEMBL9555902 | 0.80 | ALDH1A1 (0.31) | ALDH1A1 | |
| SCHEMBL10627755 | 0.77 | ALDH1A1 (0.75) | ALDH1A1CYP3A4 | |
| SCHEMBL11547470 | 0.76 | ALDH1A1 (0.74) | ALDH1A1CYP3A4 | |
| SCHEMBL17180840 | 0.75 | — | — | |
| SCHEMBL10611831 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 132 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020025848-A1 | ZWITTERIONIC COMPOUNDS OF 2-PHOSPHOCHOLINE CARBOXYLIC ACIDS AND THEIR USE AS CYTOTOXIC AGENTS | UNIVERSIDAD DE ALICANTE (ES) | 2020-02-06 | — | — | WO | claimed |
| US-20170210775-A1 | GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS | JINA PHARMACEUTICALS, INC. | 2017-07-27 | — | — | US | claimed |
| US-9637515-B2 | Guggulphospholipid methods and compositions | JINA PHARMACEUTICALS, INC. (US) | 2017-05-02 | — | — | US | claimed |
| EP-2088865-B1 | GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS | JINA PHARMACEUTICALS INC (US) | 2015-10-21 | — | — | EP | claimed |
| US-20100151002-A1 | Guggulphospholipid Methods and Compositions | JINA PHARMACEUTICALS, INC. (US) | 2010-06-17 | — | — | US | claimed |
| EP-2088865-A2 | GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS | Jina Pharmaceuticals Inc. (US) | 2009-08-19 | — | — | EP | claimed |
| US-20090202816-A1 | STABILIZED SILICA COLLOID | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2009-08-13 | — | — | US | claimed |
| WO-2008058156-A9 | GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS | JINA PHARMACEUTICALS INC (US) | 2008-12-04 | — | — | WO | claimed |
| WO-2008058156-A2 | GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS | JINA PHARMACEUTICALS INC. (US) | 2008-05-15 | — | — | WO | claimed |
| WO-2007146680-A1 | STABILIZED SILICA COLLOID | FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION , INC. (US) | 2007-12-21 | — | — | WO | claimed |
| JP-58164596-A | — | — | None | — | — | JP | disclosed |
| JP-62289588-A | — | — | None | — | — | JP | disclosed |
| CN-118019547-A | Thermostable lipid nanoparticles and methods of use thereof | 默沙东有限责任公司 | 2024-05-10 | — | — | CN | disclosed |
| WO-2020025848-A1 | ZWITTERIONIC COMPOUNDS OF 2-PHOSPHOCHOLINE CARBOXYLIC ACIDS AND THEIR USE AS CYTOTOXIC AGENTS | UNIVERSIDAD DE ALICANTE (ES) | 2020-02-06 | — | — | WO | disclosed |
| US-20170210775-A1 | GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS | JINA PHARMACEUTICALS, INC. | 2017-07-27 | — | — | US | disclosed |
| EP-0089635-A2 | Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-09-28 | — | — | EP | disclosed |
| EP-0071892-A2 | Phospholipid derivatives, process for preparation thereof and pharmaceutical composition of the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-02-16 | — | — | EP | disclosed |
| EP-0070433-A1 | Phospholipid derivatives, processes for preparation thereof and pharmaceutical composition of the same | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-01-26 | — | — | EP | disclosed |
| US-4156663-A | 260/857 R | KANEBO, LTD. (JP) | 1979-05-29 | — | — | US | disclosed |
| US-4072658-A | FLAME RETARDANTS | KANEBO, LTD. (JA) | 1978-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100151002-A1 | Guggulphospholipid Methods and Compositions | SGMS2, SGMS1, PLA2G5 | ALDH1A1 4045/4885CYP3A4 1285/4885 |
| US-20170210775-A1 | GUGGULPHOSPHOLIPID METHODS AND COMPOSITIONS | SGMS1, SGMS2, GGPS1 | ALDH1A1 3991/4885CYP3A4 764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.